poisar

Stocks · News reference

Intelligent Bio Solutions Reports 98.2% Accuracy In Codeine Study, Accelerates FDA 510(k) Submission To September 2026

BenzingaBenzinga Newsdesk

Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the results of its

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — INTELLIGENT BIO SOLUTIONS INC. (INBS)

    Filed: 2026-09-02 AccNo: 0001493152-26-041253 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits